Nasal Polyps Clinical Trial
Official title:
Recurrent Nasal Polyposis; A Two Years Retrospective Comprehensive Overview
Verified date | July 2022 |
Source | Sohag University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
A retrospective study for patients with recurrent nasal polypi operated at Otorhinolaryngology Department, Sohag University Hospital will be carried out.
Status | Completed |
Enrollment | 37 |
Est. completion date | April 30, 2022 |
Est. primary completion date | April 30, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: All patients with recurrent nasal polypi will be include in our study regardless their age and sex. Exclusion Criteria: - Exclusion criteria: Patients with nasal polyps due to underlying neoplasm will be excluded from our study. Also, those with fresh polyps or missed patients during follow up due to any reason are not candidates for our research. |
Country | Name | City | State |
---|---|---|---|
Egypt | Sohag University hospital | Sohag |
Lead Sponsor | Collaborator |
---|---|
Sohag University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Recurrent Nasal Polyposis | Aim of the work:
To evaluate patients with recurrent nasal polypi operated at Otorhinolaryngology department at sohag university hospital |
A Two Years Retrospective Comprehensive Overview |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT02071667 -
Association of Periostin Levels and Chronic Sinusitis
|
N/A | |
Completed |
NCT01623310 -
12-Month OL Intranasal Fluticasone Propionate BID Using OptiNose Device
|
Phase 3 | |
Completed |
NCT02024659 -
Effects and Safety of Budesonide Inhalation Suspension Via Transnasal Nebulization in Nasal Polyps
|
Phase 2/Phase 3 | |
Completed |
NCT00215787 -
Investigation of the Association Between Nasal Polyposis and Extraesophageal Reflux Disease
|
N/A | |
Completed |
NCT04996576 -
Infrazygomatic Versus Intranasal Injection Sphinopalatine Ganglion Blockade Effect on Surgical Field in FESS
|
N/A | |
Recruiting |
NCT03963648 -
NO Measurements in Screening for Asthma and OSA, in Patients With CRSwNP
|
N/A | |
Recruiting |
NCT05094570 -
Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP
|
Phase 4 | |
Recruiting |
NCT05009758 -
Moving Towards Precision Medicine in United Airways Disease: Unraveling Inflammatory Patterns in Asthmatic Patients With or Without Nasal Polyps
|
N/A | |
Completed |
NCT00731185 -
Mometasone Furoate Nasal Spray for Treatment of Nasal Polyposis After Surgery (Study P03218)
|
Phase 3 | |
Active, not recruiting |
NCT03943121 -
The Effects of Steroid-eluting Stent Implant for the Treatment of Eosinophilic Chronic Rhinosinusitis With Nasal Polyps
|
N/A | |
Active, not recruiting |
NCT03704415 -
Aggravated Airway Inflammation: Research on Genomics and Optimal Operative Treatment (AirGOs Operative)
|
N/A | |
Not yet recruiting |
NCT06070311 -
Wound Healing After Endoscopic Sinus Surgery
|
N/A | |
Completed |
NCT02879929 -
Development and Validity of the DyNaChron Questionnaire for Chronic Nasal Dysfunction
|
N/A | |
Recruiting |
NCT05672030 -
Role of IL-5R Signaling in Non-eosinophil Upper Airway Cells in CRSwNP
|
||
Suspended |
NCT04261582 -
Genetics and Genomics of Aspirin Exacerbated Respiratory Disease (AERD)
|
||
Recruiting |
NCT05063981 -
Treatment With Mepolizumab on Patients With Severe Refractory Eosinophilic Asthma With or Without CRSwNP.
|
||
Completed |
NCT05180357 -
RANS. Study in Patients With Severe Eosinophilic Asthma and Nasal Polyps.
|
||
Completed |
NCT00788463 -
A Comparison of Beclomethasone Aqueous Spray and Aerosol Delivery Systems in Nasal Polyps
|
Phase 2 | |
Completed |
NCT01198912 -
Influence of Oral Doxycycline on Wound Healing After Endonasal Endoscopic Sinus Surgery for Chronic Rhinosinusitis With and Without Nasal Polyposis: a Double-blind Randomized Placebo-controlled Trial
|
Phase 2 | |
Completed |
NCT03280537 -
A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitus With Nasal Polyps
|
Phase 3 |